bezafibrate
Sign in to saveAlso known as Bezalip®, Cedur, Befizal, Bezafibratum, Bezafibrato, Bezafibrat, 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid, Bezalip
Bezafibrate (marketed as Bezalip and various other brand names) is a fibrate drug used as a lipid-lowering agent to treat hyperlipidaemia. It helps to lower LDL cholesterol and triglyceride in the blood, and increase HDL.
Wikidata facts
- Mass
- 361.108
Show 5 more facts
- chemical formula
- C₁₉H₂₀ClNO₄
- canonical SMILES
- CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
- World Health Organisation international non-proprietary name
- bezafibratum
- defined daily dose
- 0.6
- Commons category
- Bezafibrate
Sources (7)
via Wikidata · CC0
~4 min read
Article
7 sectionsContents
- Medical uses
- Side effects
- Other uses
- Mode of action
- Synthesis
- History
- References
{{Drugbox | verifiedrevid = 443667625 | IUPAC_name = 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid | image = Bezafibrate.svg | image_class = skin-invert-image
| tradename = | Drugs.com = | MedlinePlus = a682711 | pregnancy_category = | legal_UK = POM | legal_US = Rx-only | routes_of_administration = Oral
Connections
Hoffmann-La Roche
Company
low-density lipoprotein
Entity
high-density lipoprotein
Entity
hypolipidemic
Entity
GW-501516
Entity
blood
Entity
liver
Entity
International Standard Book Number
Entity
drug
Entity
blood vessel
Entity
digital object identifier
Entity
chemical formula
Entity
mutation
Entity
hepatitis C
Entity
ibuprofen
Entity
molar mass
Entity
Q180686
Entity
triglyceride
Entity
dietary fiber
Entity
CAS Registry Number
Entity